The 395th Labor Policy Council, Employment Security Subcommittee, Labor Supply and Demand System Division (Meeting Announcement)

The announcement that the “395th Labor Policy Council, Employment Security Subcommittee, Labor Supply and Demand System Division” will be held on June 16, 2026, suggests that the successor problem in medical institutions is linked to overall labor supply and demand issues. The importance of third-party succession to avoid clinic closures and business failures, early consideration by chairpersons and clinic directors starting around age 60 with a 5-10 year timeframe, and the utilization of specialized advisors focused on the medical industry are emerging as particularly valuable points in this context.

Issues Surrounding “People” in Medical Institutions as Suggested by the Labor Policy Council

The announcement of the “395th Labor Policy Council, Employment Security Subcommittee, Labor Supply and Demand System Division,” scheduled for June 16, 2026, may at first glance seem unrelated to medical M&A. However, the very holding of such labor policy discussions highlights the current tight labor supply and demand balance across Japan, and the medical industry is no exception. Securing professionals such as doctors, nurses, and allied health professionals is an urgent issue directly linked to the survival of medical institutions and the maintenance of regional healthcare systems. Especially for medical corporations and clinics struggling with a lack of successors, under circumstances where internal succession is difficult, securing external personnel, and by extension, business succession to a third party, is presumed to be gaining importance as a realistic option for maintaining regional healthcare.

Medical Corporation Business Succession: Approaching with a “5-10 Year Timeframe” from Age 60

The point in the news summary, “chairpersons and clinic directors preparing with a 5-10 year timeframe starting around age 60,” accurately captures the practical importance of business succession for medical corporations. Compared to general companies, the succession of medical institutions involves complex legal regulations (such as the Medical Care Act, Medical Practitioners’ Act, and Pharmaceuticals and Medical Devices Act), requiring a considerable amount of preparation time. For example, in the case of a medical corporation with equity interests, the valuation and transfer of equity, procedures for changing members and directors at board meetings and general meetings of members, changes to clinic establishment permits and medical corporation establishment approvals, succession of facility standards, and consideration of tax aspects such as capital gains tax, gift tax, and inheritance tax are all indispensable. To smoothly proceed with these procedures, planning and execution from a long-term perspective of at least 5 years, and in some cases 10 years, are required. Starting consideration around age 60 can be considered a realistic timeline to secure options and achieve a well-prepared succession.

The Strategic Value of “Third-Party Succession” to Avoid Clinic Closures and Business Failures

Clinic closures and business failures due to lack of successors not only mean the loss of healthcare access for local residents but also the loss of the medical institution’s brand built over many years, its clinical know-how, and the employment opportunities for its staff. As the labor supply and demand issues suggested by this news become more severe, third-party succession becomes an effective strategy to avoid these losses and pass on the value of the medical institution to the next generation. For potential buyers, succeeding an existing medical institution offers advantages over new establishment, such as saving the effort of obtaining permits and licenses, securing an established patient base, experienced medical staff, and stable medical fee revenue early on. M&A support organizations specializing in the medical industry are indispensable in comprehensively supporting these complex legal, tax, and financial aspects, and in building optimal succession schemes for both sellers and buyers.

If you are specifically considering the succession or M&A of a medical corporation or clinic, please use our free quick assessment or individual consultation (strict confidentiality, fully success-based fee system).